Imaging of brain metastases

Surgical Neurology International

Volumn 4, Issue SUPPL4, 2013, Pages

  Fink, Kathleen ^a   Fink, James ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastasis; computed tomography; diffusion weighted imaging; magnetic resonance imaging; magnetic resonance perfusion; magnetic resonance spectroscopy

Indexed keywords

GADODIAMIDE; GADOLINIUM; GADOTERIDOL;

ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER PATIENT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED MAGNETIC RESONANCE PERFUSION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOMA; HISTOPATHOLOGY; HUMAN; MENINGEAL METASTASIS; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS;

EID: 84877995230     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.111298     Document Type: Article

References (57)

1. Magnetic Resonance Imaging of the Brain and Spine. Magnetic Resonance Imaging of the Brain and Spine. In: Atlas SW, Atlas SW, editor. 4 th ed, Vol. 2. Philadelphia: Wolters Kluwer Health/Lippincott Williams and Wilkins; 2009
2. Akeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtås S. Brain metastases-comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Acta Radiol 1995;36:300-6
3. Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006;26 Suppl 1:S173-89
4. Balériaux D, Colosimo C, Ruscalleda J, Korves M, Schneider G, Bohndorf K, et al. Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology 2002;44:191-203
5. Barajas RF, Cha S. Imaging diagnosis of brain metastasis. Prog Neurol Surg 2012;25:55-73
6. Bendini M, Marton E, Feletti A, Rossi S, Curtolo S, Inches I, et al. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients. Acta Neurochir (Wien) 2011;153:403-12
7. Blatt DR, Friedman WA, Agee OF. Delayed computed tomography contrast enhancement patterns in biopsy proven cases. Neurosurgery 1993;32:560-9
8. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24:225-33
9. Byrnes TJ, Barrick TR, Bell BA, Clark CA. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed 2011;24:54-60
10. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394-403
11. Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078-84
12. Chen XZ, Ying XM, Ai L, Chen Q, Li SW, Dai JP. Differentiation between Brain Glioblastoma Multiforme and Solitary Metastasis: Qualitative and Quantitative Analysis Based on Routine MR Imaging. AJNR Am J Neuroradiol 2012;33:1907-12
13. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004;46:619-27
14. Davis PC, Hudgins PA, Peterman SB, Hoffman JC. Diagnosis of cerebral metastases: Double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:293-300
15. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988;45:741-4
16. Duygulu G, Ovali GY, Calli C, Kitis O, Yünten N, Akalin T, et al. Intracerebral metastasis showing restricted diffusion: correlation with histopathologic findings. Eur J Radiol 2010;74:117-20
17. Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004;59:77-85
18. Ginaldi S, Wallace S, Shalen P, Luna M, Handel S. Cranial computed tomography of malignant melanoma. AJR Am J Roentgenol 1981;136:145-9
19. Grossman ZD. Cost-effective diagnostic imaging: The clinicians guide. 4, illustrated ed. Philadelphia, Pa.: Mosby; 2006
20. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24:817-24
21. Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M. Solitary metastases and high-grade gliomas: Radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 2010;65:15-20
22. Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, et al. Diffusion-weighted imaging of metastatic brain tumors: Comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006;27:1419-25
23. Healy ME, Hesselink JR, Press GA, Middleton MS. Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 1987;165:619-24
24. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D, et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006;27:1404-11
25. Hwang TL, Close TP, Grego JM, Brannon WL, Gonzales F. Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 1996;77:1551-5
26. Ishimaru H, Morikawa M, Iwanaga S, Kaminogo M, Ochi M, Hayashi K. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 2001;11:1784-91
27. Kaal EC, Taphoorn MJ, Vecht CJ. Symptomatic management and imaging of brain metastases. J Neurooncol 2005;75:15-20
28. Kremer, Grand, Berger, Hoffmann, Pasquier, Rémy, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003;45:44-9
29. Krüger S, Mottaghy FM, Buck AK, Maschke S, Kley H, Frechen D, et al. Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging. Nuklearmedizin 2011;50:101-6
30. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715-21
31. Lee EJ, terBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, et al. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol 2011;196:71-6
32. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24:937-41
33. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212:803-9
34. McGann GM, Platts A. Computed tomography of cranial metastatic malignant melanoma: Features, early detection and unusual cases. Br J Radiol 1991;64:310-3
35. Meyer PC, Reah TG. Secondary neoplasms of the central nervous system and meninges. Br J Cancer 1953;7:438-48
36. Nadal Desbarats L, Herlidou S, de Marco G, Gondry-Jouet C, Le Gars D, Deramond H, et al. Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. Magn Reson Imaging 2003;21:645-50
37. Nagai A, Shibamoto Y, Mori Y, Hashizume C, Hagiwara M, Kobayashi T. Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning. Neuro Oncol 2010;12:1187-92
38. Nakase H, Sakaki T, Fujita T, Tsunoda S, Nakamura M, Imai T, et al. Multiple calcified metastatic brain tumor - case report. Neurol Med Chir (Tokyo) 1991;31:787-91
39. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. Whole-body MR imaging vs. FDG-PET: Comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007;26:498-509
40. Osborn AG. Diagnostic imaging: Brain. Volume 2 of Diagnostic Imaging Series. illustrated ed. Salt Lake City, Utah: Amirsys; 2004
41. Potts DG, Abbott GF, von Sneidern JV. National Cancer Institute study: evaluation of computed tomography in the diagnosis of intracranial neoplasms. III. Metastatic tumors. Radiology 1980;136:657-64
42. Rohren EM, Provenzale JM, Barboriak DP, Coleman RE. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 2003;226:181-7
43. Runge VM, Kirsch JE, Burke VJ, Price AC, Nelson KL, Thomas GS, et al. High-dose gadoteridol in MR imaging of intracranial neoplasms. J Magn Reson Imaging 1992;2:9-18
44. Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999;44:275-81
45. Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, et al. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol 2010;51:316-25
46. Shalen PR, Hayman LA, Wallace S, Handel SF. Protocol for delayed contrast enhancement in computed tomography of cerebral neoplasia. Radiology 1981;139:397-402
47. Sidhu KP, Cooper P, Ramani R, Schwartz M, Franssen E, Davey P. Delineation of brain metastases on CT images for planning radiosurgery: Concerns regarding accuracy. Br J Radiol 2004;77:39-42
48. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2 nd edition). Chest 2007;132 (3 Suppl):178S-201
49. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: Report of an EFNS Task Force. Eur J Neurol 2006;13:674-81
50. Sze G, Krol G, Olsen WL, Harper PS, Galicich JH, Heier LA, et al. Hemorrhagic neoplasms: MR mimics of occult vascular malformations. AJR Am J Roentgenol 1987;149:1223-30
51. Sze G, Shin J, Krol G, Johnson C, Liu D, Deck MD. Intraparenchymal brain metastases: MR imaging versus contrast-enhanced CT. Radiology 1988;168:187-94
52. Tsuchiya K, Fujikawa A, Nakajima M, Honya K. Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging. Br J Radiol 2005;78:533-7
53. Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507-14
54. Williams RL, Meltzer CC, Smirniotopoulos JG, Fukui MB, Inman M. Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol 1998;19:427-31
55. Yamamoto A, Kikuchi Y, Homma K, O′uchi T, Furui S. Characteristics of intravascular large B-cell lymphoma on cerebral MR imaging. AJNR Am J Neuroradiol 2012;33:292-6
56. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: A comparison of CT and MRI. Chest 1999;115:714-9
57. Yuh WT, Fisher DJ, Runge VM, Atlas SW, Harms SE, Maravilla KR, et al. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994;15:1037-51